3D Bioprinting Market report explores Scope of the Study as Research Objective, Assumptions and Limitations in-depth. The report gives Market Dynamics by Drivers, Restraints, Opportunities, Challenges, Macroeconomic Indicators and Technology Trends & Assessment.
Pune, India -- (SBWIRE) -- 12/21/2018 -- The Global 3D Bioprinting Market is growing at a reasonable pace, mainly due to R&D investment and government funding which is set to increase the market at a quicker rate. According to a recent study report published by the Market Research Future, the global 3D bioprinting market is booming and expected to gain prominence over the forecast period growing rapidly. The market is forecasted to demonstrate a spectacular growth by 2023, surpassing its previous growth records in terms of value with a striking CAGR of ~25% during the anticipated period (2017 – 2023).
Moreover, the market for 3D bioprinting is growing due to the increasing demand for bioprinting in the healthcare sector, high prevalence of chronic diseases, increasing number of organ transplants, and extensive research & development activities. Furthermore, growing stem cell research and increasing adoption of 3D bioprinting in cosmetic industry are expected to create ample growth opportunities for the global market. However, the high cost of 3D bioprinting, lack of skilled professionals and stringent regulatory processes are the key barriers for the growth of the global market.
Get Sample Report @ https://www.marketresearchfuture.com/sample_request/869
Global 3D bioprinting Market - Competitive Analysis
Different companies along with academic institutes and laboratories are investing a huge capital for 3D bioprinting research and development has supported the market growth. Key players in the market are involved in extensive R&D activities to use stem cells for bioprinting tissues, which drives the growth of this market. For instance, Materialise is one of the major players in this market. The company manufactures 3D bioprinters, and also undertakes 3D printing of anatomical models. In June 2017, Materialise improved 3D imaging and printing- clinical trials conducted in the U.S.
Additionally, in March 2017, the company announced FDA clearance for their 3D-printed patient-specific radius and ulna osteotomy guides for children. In May 2017, the company announced they would begin production of 3D bioprinter using technology-HP Jet Fusion 3D 4200.
Companies like Organovo, which are printing human tissues with the help of 3D bioprinters, developed in collaboration with Invetech, will lead us into the future of medicine. As the 3D bioprinting technology advances, synthetic body organs and artificial tissues will become a reality in future.
Moreover, Organovo Holding Inc. participated in conferences such as Cantor Fitzgerald Inaugural Healthcare Conference in 2015, in order to increase awareness regarding their current activities in the field of 3D bioprinting. The company also announced a partnership with L'Oreal in the field of hair and skin care to develop skin tissue using their NovoGen Bioprinting Platform. Therefore, the various key developments in the area of 3D bioprinting has upsurged the growth of the market.
3D Bioprinting Market – Key Players
Key market contributors are
Stratasys Ltd. (U.S.)
ORGANOVO HOLDINGS, INC. (U.S.)
Aspect Biosystems Ltd. (Canada)
CELLINK AB (Sweden)
Bio3D Technologies (Singapore)
ENVISIONTEC, INC. (Germany)
3D Bioprinting Market - Regional Analysis
Geographically, the market has been segmented into the Americas, Asia Pacific (APAC), Europe, and the Middle East & Africa (MEA).
The Americas hold the maximum share owing to a well-structured healthcare sector and heavy investment both by the government and the private players. A large base of patient population waiting for transplantation is also a market booster. Healthcare expenditure due to a rise in disposable income and the presence of significant market players are proving to be significant contributors.
Europe is the second largest market with a cluster of developed countries such as France, Germany and the U.K. who are spending heavily on the technology and is always eager to innovate.
APAC is the fastest growing region with continuously growing population and burgeoning healthcare sector in developing countries such as China and India. According to the Indian Brand Equity Foundation in 2017, the Indian market is deemed to grow with an astonishing CAGR of 22.87% by 2020 and touch USD 280 billion.
MEA is unlikely to get a huge boost owing to the presence of several poor countries in the region. Qatar, Kuwait, Saudi Arabia, and Dubai are the few countries with advanced healthcare infrastructure and interested in research investments.
Browse Complete Premium Research Report Enabled with Tables and Figures @ https://www.marketresearchfuture.com/reports/3d-bioprinting-market-869
3D Bioprinting Market - Segmentation
The Global 3D Bioprinting technology can be segmented by technology, material, application, and end-users.
Technology-wise segmentation includes electron beam melting, laser beam melting, droplet disposition, syringe extrusion, magnetic levitation, and others. Syringe extrusion is expected to hold the maximum share in the market. Meanwhile, magnetic levitation is estimated to grow with the fastest CAGR during the prognosis period. Magnetic levitation allows usage of cheap printing machine is making the segment more consumer-friendly. Sub-segments of laser beam melting are photopolymerization, stereo lithography, two-photon polymerization, and others. The droplet disposition can further be sub-segmented into inkjet printing, fused disposition methods, multi-phase jet solidification, and others.
Based on the material, the market is comprised of cells, hydrogels, extracellular matrices, fibrinogen, alginate, and others. Cells are the current rage in the market and hold the maximum share as researchers are structuring their research plans on these cells.
Application-based segmentation consists clinical, research, and others. The clinical segment has sub-segments, namely, tissue transplantation, bone grafts, vascular grafts, wound care, and others. The wound care segment has acute wounds, chronic wounds, hernia repair, and others. The research segment has regenerative medicine, personalized healthcare, 3D cell culture, and others. The last segment is expected to dominate the market and grow at a stellar pace as various market players and universities are funding researches to take the developments to an unprecedented level.
The end-user segment includes pharmaceutical & biotechnology companies, research organization, academic institutes, and others.
Major Table of Content
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.2 Scope of the Study
2.2.1 Research Objective
Chapter 3. Research Methodology
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
To Know More Enquire @ https://www.marketresearchfuture.com/enquiry/869
About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.